Our present study aims to initiate TXA administration immediately upon diagnosis of hip
fracture in the Emergency Department. This will be a single blind randomized controlled trial
comparing early administration of TXA in the ED in addition to perioperative dosing versus
the standard perioperative administration only. The study population will include patients
who have sustained a femoral neck, intertrochanteric, or subtrochanteric femur fracture and
are undergoing surgical internal fixation or arthroplasty. We will prospectively compare the
need for blood transfusion, total and hidden blood loss, postoperative complications, length
of stay and readmission within 30 days.